Nonlinear system identification for prostate cancer and optimality of intermittent androgen suppression therapy.
暂无分享,去创建一个
[1] N. Bruchovsky,et al. Hormonal effects on cell proliferation in rat prostate. , 1975, Vitamins and hormones.
[2] Kazuyuki Aihara,et al. Nonlinear systems identification by combining regression with bootstrap resampling. , 2011, Chaos.
[3] N. Kyprianou,et al. Quantal relationship between prostatic dihydrotestosterone and prostatic cell content: Critical threshold concept , 1987, The Prostate.
[4] Hagai Attias,et al. Inferring Parameters and Structure of Latent Variable Models by Variational Bayes , 1999, UAI.
[5] Lyle Noakes,et al. THE TAKENS EMBEDDING THEOREM , 1991 .
[6] Naonori Ueda,et al. Bayesian model search for mixture models based on optimizing variational bounds , 2002, Neural Networks.
[7] Nicholas Bruchovsky,et al. Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer , 2006, Cancer.
[8] Mohammad H. Rashid,et al. Intermittent androgen deprivation therapy for prostate cancer. , 2004, The oncologist.
[9] Arjan van der Schaft,et al. Complementarity modelling of hybrid systems , 1997 .
[10] G. Williams,et al. Intermittent androgen deprivation after PSA-complete response as a strategy to reduce induction of hormone-resistant prostate cancer. , 1997, Urology.
[11] A. J. van der Schaft,et al. Complementarity modeling of hybrid systems , 1998, IEEE Trans. Autom. Control..
[12] Alberto Bemporad,et al. On the Optimal Control Law for Linear Discrete Time Hybrid Systems , 2002, HSCC.
[13] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[14] Kazuyuki Aihara,et al. Piecewise affine systems modelling for optimizing hormone therapy of prostate cancer , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[15] A. Coldman,et al. Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. , 1990, Cancer research.
[16] L. Klotz,et al. Intermittent endocrine therapy for advanced prostate cancer , 1986, Cancer.
[17] M. Morari,et al. Optimal controllers for hybrid systems: stability and piecewise linear explicit form , 2000, Proceedings of the 39th IEEE Conference on Decision and Control (Cat. No.00CH37187).
[18] M. Gleave,et al. Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report. , 1995, Urology.
[19] W. Ellis,et al. Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study. , 1996, Urology.
[20] Hideyuki Suzuki,et al. Theory of hybrid dynamical systems and its applications to biological and medical systems , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[21] C. Huggins,et al. STUDIES ON PROSTATIC CANCER: II. THE EFFECTS OF CASTRATION ON ADVANCED CARCINOMA OF THE PROSTATE GLAND , 1941 .
[22] Kazuyuki Aihara,et al. Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer. , 2010, Journal of theoretical biology.
[23] Bart De Schutter,et al. Equivalence of hybrid dynamical models , 2001, Autom..
[24] R. Noble. Hormonal control of growth and progression in tumors of Nb rats and a theory of action. , 1977, Cancer research.
[25] A. Evens,et al. Intermittent Androgen Suppression as a Treatment for Prostate Cancer: A Review. , 1998, The oncologist.
[26] O. Mangasarian,et al. Multicategory discrimination via linear programming , 1994 .
[27] F. Takens. Detecting strange attractors in turbulence , 1981 .
[28] D. Rubin,et al. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .
[29] Eduardo Sontag. Nonlinear regulation: The piecewise linear approach , 1981 .
[30] C. Huggins,et al. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.
[31] S. Goldenberg,et al. Effects of intermittent androgen suppression on androgen‐dependent tumors. Apoptosis and serum prostate‐specific antigen , 1993, Cancer.
[32] T. Jacks,et al. Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Crook,et al. Intermittent androgen suppression in the management of prostate cancer. , 1999, Urology.
[34] Kristin P. Bennett,et al. Multicategory Classification by Support Vector Machines , 1999, Comput. Optim. Appl..